This paper records a study of meningococcus strains made in connection with the production of therapeutic antimeningococcus serum. The serum distributed routinely by this laboratory since 1919 has been produced with six strains which were selected after careful serological and immunological tests as representative of the main groups of meningococci (1, 2). The broad antigenic capacities of these strains have since been confirmed both by laboratory tests and by the clinical results obtained with the serum (3, 4, 5).
IMMTJNOLOGICAL REACTIONS OF MENINGOCOCCUS STRAINS.
4 4 5 From 1916 to December 31, 1930 , 441 meningococcus strains have been received. Practically all strains were isolated from spinal fluid, rarely from either blood or nasopharyngeal cultures. Strains obtained since 1919 were isolated from cases occurring in various localities throughout the United States and also include six from Mexico, as well as two received from the Pasteur Institute. The strains received earlier were obtained from the Rockefeller Institute. In addition to these, English strains representative of Gordon's groups, and the standard strains from the National Institute of Health, have also been studied. The morphological and cultural characteristics of each strain were determined on its receipt by the examination of microscopic preparations, of the growth on blood-agar plates and on dextroseserum-agar slants. The fermentative activity was tested for dextrose, maltose, saccharose, and lactose in ascitic-fluid agar with phenol red as an indicator (6).
In determining the incidence of groups, the system of classification established at the Second International Conference on the Standardization of Sera and Serological Tests, held in Paris in 1922 (7), has been used. However, in addition to the main groups I and II, we have found it convenient to retain the group which corresponds to Gordon's group III.
Studies on the classification of meningococci by different workers, particularly those of Dopter (8) , Gordon (9) , and Nicolle, Debains and Jouan (10) , have brought into use various systems among which there is a general relationship as is shown by Murray (11) , but which give rise to confusion due to the differences in nomenclature. In order to establish international uniformity of nomenclature, the Second Conference (Paris 1922) recommended a primary division of meningococci into two groups, I and II, to be based on agglutination reactions alone and subdivision into subgroups which could be based on both agglutination and absorption tests. Strains which could not be accurately identified were to be classified under a group "X."
Published reports on classification studies since 1922 have, in general, however, served to add to the confusion and to emphasize the arbitrary status of present systems of classifications. Kristensen and Molkte (12) found it was practically impossible to make any generally applicable, definite division of meningococci into groups or types, due to the endless variation in serological reactions among them. Jotten (13) was unable to show any relationship between several German groups and groups found elsewhere. Kondo (14) has divided forty-three meningococcus strains into thirteen types according to their agglutination reactions. Assumpcao (15) was unable to classify thirty per cent of the strains isolated since 1924 in Sao Paulo, Brazil, on the basis of agglutination reactions, in either French or American group sera.
On the other hand, Branham, Taft and Carlin (16) formed a distinct homogenous group, a chromogenic species, all the strains of which were isolated from cases of meningitis in Chicago (17) . Cameron (18) has also described a similar chromogenic species obtained from cases in Chicago differing from BraDham's strain in irregular fermentation reactions.
The results of the classification made in this laboratory of fiftythree strains, undertaken for the purpose of selecting standard strains for serum production, were published in 1921 (1) . The division of these strains into groups was based mainly on agglutination reactions, since results of absorption tests made with a number of the strains confirmed those of the agglutination tests. Eighty-three per cent of this series could be identified with one or another of the first three groups of Gordon's classification. None of the cultures fell into group IV, which, according to unpublished studies made at that time, appeared to be a heterogenous group, considerable variation having occurred among group-IV strains received from different laboratories.
As a result of these early studies, six representative strains were selected for the production and standardization of therapeutic serum. Since 1919, monovalent rabbit sera for use in classification have also been produced with these strains. The routine method (6) used in this laboratory for the production of monovalent sera has, in general, been followed. Since 1926, an equal volume of glycerol has been added to the serum. The majority of the routine glycerolated sera have had titers of from 1 : 1000 to 1 : 2000, the titer representing the highest dilution in which agglutination visible to the unaided eye has occurred. When selected as standards, the groups-I and -III strains showed some evidence of the well recognized relationship between these groups. However, rabbit sera produced with group-I or group-Ill strain from 1918 through 1924, gave only slight crossagglutination reactions, insufficient to confuse classification. Group II appeared to be distinct. Classification of meningococci since 1919 has been based on their agglutination reactions in sera produced with these standard strains, agglutination tests having been performed according to the procedure used for the standardization of antimeningococcus serum (6). Usually, strains have been classified if they were agglutinated by any one group serum in a dilution of 1 : 400 or more with no cross agglutination in the other group sera or if they were agglutinated in a dilution of 1 : 500 or 1 : 800 with cross agglutination of 1 : 100 or 1 : 200 respectively.
In the special instances in which absorption tests have been done, the technic used in the early work has been employed with a few modifications. Recent absorption tests have included the testing of the mutual absorptive capacities of strains (19) . The concentration of the suspension of a strain necessary to absorb the homologous serum to from 1/8 to 1/16 of its titer has been determined, and suspensions of that concentration have been used when the serum was absorbed with either homologous or heterologous strains. Suspensions of organisms were standardized by determining the amount of physiological salt solution necessary to dilute 0.1 of a cc. of suspension to the density of a BaSo 4 standard no. 3 (6) which approximates a suspension of meningococci containing 2000 million organisms per cc. Table 1 indicates the incidence of groups since 1919. The high percentage of strains of group I or III and the very low incidence of strains of group II in recent years is in marked contrast to the incidence of groups among the strains tested from 1919 to 1927. Most of the 326 strains received during the period 1928 to 1930 represent the group incidence in epidemic centers, and in certain localities showing a markedly increased number of cases of meningococcus meningitis. One hundred and seventy-one of these strains were from cases in New York City, fifty-three from cases elsewhere in the state, fourteen from Indianapolis, twenty-one from Chicago, twelve from Baltimore, twenty-seven from New Haven, and the remaining twenty-eight strains were from Boston, Detroit, Philadelphia, Mexico, etc. Although it has been suggested that the incitant of various recent epidemics was a particularly virulent group-Ill strain, in no instances of our series were organisms of only one group isolated from any one epidemic center. These results are in accordance with those reported by Branham (16) . The number of strains which could not be classified by the agglutination test except as group " I or I I I " shows a striking increase in the larger series studied in recent years. As mentioned earlier, the standard groups-I and -III strains when selected, gave group-specific serological reactions. The group-I strains were not agglutinated by the group-Ill sera except in low dilutions, nor were group-Ill strains agglutinated to any extent by group-I sera. The results of absorption tests made at that time gave additional evidence of the group specificity of these strains. A gradual convergence in serological reactions, however, has been noted. Table 2 indicates the gradual increase in TABLE 2 .
Gradual convergence in agglutination reactions of groups I and III meningococcus strains
as indicated by the agglutinative titers of sera on repeated tests. cross reactions between groups-I and -III strains in both group-I and group-Ill sera produced several years ago. Cross agglutination occurred only in comparatively low dilutions of these sera or not at all, when first tested. In the final tests made about two years later, groups-I and -III strains were agglutinated equally well by both sera. Such reactions are new, in general, obtained with these strains which can, moreover, scarcely be differentiated by tests of mutual absorptive capacities. In 
* Highest dilution used; 1:200 was the lowest dilution used. f Routine method of immunization slightly modified because other rabbits had not survived immunization with these strains. In the few instances in which the results of duplicate tests have been available, average titers are given. • § For the other sera produced with these antigens see certain recently isolated strains are agglutinated specifically by the standard group-I or group-Ill serum. Absorption tests of standard sera with such recently isolated strains give further evidence of a slight but definite serological difference between the standard strains.
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The differentiation between closely related strains of group I and III does not seem to be of any practical value. However, in selecting strains for the production of therapeutic serum the recognition of some difference between these groups may be of considerable importance. The efficacy of state serum in recent cases of meningococcus meningitis may have been due in part to the fact that four of the six strains used in the immunization of horses are group -I or -III strains possessing broad and overlapping, but somewhat different, antigenic complexes. The percentage of group " X " or atypical strains in our series is comparatively high (29.2 per cent), due, no doubt, to the fact that no attempt has been made to classify these strains except on the basis of results of the routine agglutination tests. This group includes strains which agglutinate similarly in relatively high dilutions of groups-I, -II, and -III sera as well as those agglutinating not at all or only in very low dilutions of any or all of the three group sera. About twenty-five per cent of the strains which are classified as group " X " when first received can, on retests made from two months to a year later, be definitely grouped. Thus, it has been possible to reduce the number of strains classified as group " X " to 29.2 per cent (table 1) from 33.9 per cent as given in a recent paper (5) . Only one of the strains of group " X " received since 1918, was not agglutinated by polyvalent serum and in recent tests only eight were agglutinated in dilutions of less than 1 : 500, the majority being agglutinated in dilutions of from 1 : 1000 to 1 : 3000. These reactions in the polyvalent serum produced with groups -I, -II, and -III strains suggests that these group " X " strains are related in some degree to the main groups. This group includes no strain similar to the chromogenic species described by Branham (17) and by Cameron (18) . Not only the agglutination reactions of atypical strains but also the clinical results in cases from which such strains are isolated emphasize the high degree of polyvalency of the six-strain therapeutic serum and the broad antigenic character of the standard strains. In a small series on which we have complete data, the mortality rate for thirty-three cases from which atypical strains were isolated, and which were treated with the state serum, was 21.2 per cent.
The incidence of strains belonging to Gordon's group IV has been very low in this country. In the early series of strains studied in this laboratory, no group-IV strains were found and, therefore, no strain of this group was selected for use in the immunization of horses. A group-IV strain is included among the National Institute of Health standard strains and cultures related to it have been isolated from cases in a recent epidemic in Chicago (15) . Therefore, it seemed desirable to determine whether there were similar strains among the group " X " or atypical cultures which we have received since 1927.
The federal standard and two group-IV strains isolated from cases in Chicago in 1928, were received from the National Institute of Health and were tested for agglutination reactions and antigenic properties. They were not agglutinated by monovalent group-I, -II or -III sera and were agglutinated only in low dilution, or not at all, by the state polyvalent serum. High titered and specific monovalent sera were produced in rabbits with these three strains. The federal standard strain was found to differ from an English Gordon-IV strain, "Hicks," received from Doctor W. H. Park. The English strain is well agglutinated by the state polyvalent serum and seems to be related in some degree to group II. In our tests monovalent serum produced with the English strain does not agglutinate any of the three American group-IV strains tested, nor is the English strain agglutinated by the federal standard group-IV serum. On the other hand, this strain is agglutinated by sera produced with the Chicago group-IV strains. The federal standard strain possesses apparently narrow immunological characteristics and has very little relation to any of Gordon's four groups while the recent Chicago strains seem to be related to both the federal strain and Gordon's group IV.
Seventy-four of the ninety-one strains classified in group " X " since 1927 have been tested in both federal group-IV and in Gordon-IV-" Hicks" sera. None of the atypical cultures tested were agglutinated to any extent by the sera produced with these strains, with the exception of the two Chicago strains. The seventeen strains which were not tested in the group-IV sera were agglutinated in relatively high dilutions of polyvalent serum, in the production of which only groups-I, -II, and -III strains are used. It is questionable, on account of their limited incidence, whether group-IV strains are at' present essential in the production of therapeutic sera. However, if group-IV strains are used, it would seem desirable to select strains similar to those isolated in Chicago which possess broad antigenic capacities.
Comparative tests of the antigenic quality of seventeen epidemic and other recently isolated strains and of the six state standard strains used in immunization of horses, as well as of the federal standard strains have been made. The recent strains were selected, as representative of different outbreaks, for their definite serological reactions or because of the case histories. They included five strains obtained from New York City in 1928 during the markedly increased incidence of meningococcus meningitis, and four from the National Institute of Health, which had been selected as representative of groups-I and -III strains of recent epidemics. Two rabbits were immunized with each strain according to the routine method for the production of monovalent antimeningococcus serum (6). The agglutinative titers of the sera were used as criteria in estimating the comparative antigenic potency. Table 3 gives the results obtained with twelve recent strains in comparison with those with three of the state strains used in serum production. The results with the five New York City strains received in 1928, which are not included in the table, were very similar.
None of the sera produced with the recently isolated strains of group I or III were of markedly higher agglutinative titer or broader valency than the state monovalent sera with which they were compared, with the exception of one of the sera produced with strain Mg. 355. With one of the strains sera were obtained which were of lower titer than the sera produced with the state strains; the other ten strains produced sera which approximated the state routine monovalent sera.
The five recent group-II strains tested were found to produce sera of higher titer than that produced by one of the state standard group-II strains, although they were not superior to the sera obtained with the other group-II strain which is also used in the production of therapeutic serum.
In a comparison of the different standard strains as antigens, the following observations from the limited number of sera studied may be noted (table 4): The federal standard group-II strain produced sera which gave relatively marked cross agglutination with groups-I and -III strains. The titers of these sera were also lower than those, with one exception, produced with other group-II strains. Sera which had been produced in December, 1928, with transplants of the federal group-I or -III strains received about four months previously, were found to have equal or higher agglutinative titers than the state standard monovalent sera.
The standard groups-I and -III strains were further compared in agglutination and absorption reactions, using transplants of the federal strains received in June, 1930. Table 5 gives the results obtained.
Some differentiation between the state groups-I and -III strains was obtained by means of absorption tests of group-I sera, particularly with the serum produced with strain 79B. However, when group-III sera were absorbed with either group-I or group-III strains, complete absorption or a marked reduction in agglutination reaction occurred with strains of both groups. A state standard group-II strain which was also tested gave scarcely any cross agglutination or absorption reactions with the other groups. The federal groups-I and -III strains also could not be classified by means of the absorption test. Strain H.L. 123 (I), when tested in group-I sera, produced with W60B or 79B. gave absorption reactions similar to those of the group-III strains 10B and W30B, but when group-III sera were absorbed with H.L. 123 (I), absorption was not complete. Strain H.L. 57 (III) appeared to have narrow absorptive capacity in that with one exception it absorbed completely only the homologous agglutination from sera produced with either the state or federal strains of both groups. Agglutination results obtained with the federal groups-I and -III strains received and tested in 1930 did not correspond with those obtained with transplants received and tested two years earlier. Strain H.L. 57 (III), moreover, failed in the recent absorption tests to absorb its homologous serum. These results suggested the occurrence of some change in these strains since 1928.
Strain H.L. 123 (I) apparently is not closely related, according to these tests, to the state strains W60B (I) or 79B (I), nor is strain H.L. 57 (III) to the state strains W30B (III) or 10B (III). The state group-III strains, in particular, are of broader valency than the federal strain. From the viewpoint of serum production, strains with a high degree of valency appear to have advantages; in classification, on the other hand, grouping may be facilitated by selecting strains of limited valency.
Conclusions. 1. The serological reactions of four hundred and forty-one strains of the meningococcus are recorded. One hundred and fifteen received from 1916 through 1927 were classified as follows: Group-I, 8.7 per cent, group-II, 33 per cent, group-III, 24.3 per cent, group-I or -III, 0.9 per cent, and group "X," 33 per cent; three hundred and twenty-six strains received from 1928 through 1930, as follows: Group-I, 24.5 per cent, group-II, 3.9 per cent, group-III, 15.3 per cent, group-I or -III, 28.2 per cent, group "X," 27.9 per cent.
2. As a result of long continued artificial cultivation, the state standard groups -I and -III strains have become very similar in agglutination and agglutinogenic reactions. It is considered important, however, for purposes of therapeutic serum production, to continue to recognize both groups.
3. The marked agglutinative activity of a six-strain polyvalent serum produced with carefully selected representative strains of groups I, II, and III for the majority of the unclassified strains indicates some relationship of these strains to the primary groups. None of these atypical strains were classified with either the American or English group-IV strains.
4. The American group IV, as represented by the federal standard strain, does not appear to be related to the English group IV according to the results of agglutination tests. A strain recently isolated in this country is allied with both the federal and English strains and may represent a broad group which includes all three.
5. Wide variation was obtained in the agglutination titers of sera from rabbits immunized with carefully selected strains from recent cases of meningitis. None of these strains was apparently markedly superior antigenically to the state strains used for more than thirteen years in serum production.
6. The state standard strains compared favorably in the valency of their serological reactions and, in general, in antigenic activity with the federal strains. The groups-I and -III strains of the two standards were not closely related.
7. Further laboratory study and clinical data are required before replacement of the present state strains by recently isolated strains is made in the routine production of the therapeutic serum.
